Aequus Pharmaceuticals (TSXV:AQS) Accumulated Depreciation : C$-0.75 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Aequus Pharmaceuticals's quarterly accumulated depreciation increased from Jun. 2024 (C$-0.68 Mil) to Sep. 2024 (C$-0.71 Mil) and increased from Sep. 2024 (C$-0.71 Mil) to Dec. 2024 (C$-0.75 Mil).

Aequus Pharmaceuticals's annual accumulated depreciation increased from Dec. 2022 (C$-0.52 Mil) to Dec. 2023 (C$-0.62 Mil) and increased from Dec. 2023 (C$-0.62 Mil) to Dec. 2024 (C$-0.75 Mil).

Aequus Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Aequus Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Accumulated Depreciation Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-0.31

-0.39

-0.52

-0.62

-0.75

Aequus Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial															-0.62	-0.65	-0.68	-0.71	-0.75

Aequus Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Aequus Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (TSXV:AQS) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

AQSZF:USA AEQ:Germany

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Executives

Doug Janzen

Director, Senior Officer

Aequus Pharmaceuticals Headlines

No Headlines